Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease

Roger Guy Pertwee; Geoffrey W Guy; Joanna Jamontt; Philip Robson

Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease

Roger Guy Pertwee (Inventor)
, Geoffrey W Guy (Inventor)
, Joanna Jamontt (Inventor)
, Philip Robson (Inventor)

Medical Sciences

Research output: Patent

Abstract

The present invention relates to the use of a substantially pure tetrahydrocannabinol (THC) or a THC containing extract in which THC is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. A further embodiment of the invention relates to the use of a substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. Additionally the substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid are used in the manufacture of a medicament for use as an adjunct therapy in the treatment of an inflammatory bowel disease.

Original language	English
Patent number	WO2009004302
IPC	A61K31/05; A61K31/352; A61K36/185; A61P19/08;
Publication status	Published - 8 Jan 2009

Cite this

@misc{53841a2913e24b5bbdf87f5dd9b5498e,

title = "Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease",

abstract = "The present invention relates to the use of a substantially pure tetrahydrocannabinol (THC) or a THC containing extract in which THC is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. A further embodiment of the invention relates to the use of a substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. Additionally the substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid are used in the manufacture of a medicament for use as an adjunct therapy in the treatment of an inflammatory bowel disease. ",

author = "Pertwee, \{Roger Guy\} and Guy, \{Geoffrey W\} and Joanna Jamontt and Philip Robson",

year = "2009",

month = jan,

day = "8",

language = "English",

type = "Patent",

note = "WO2009004302; A61K31/05; A61K31/352; A61K36/185; A61P19/08; ",

}

TY - PAT

T1 - Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease

AU - Pertwee, Roger Guy

AU - Guy, Geoffrey W

AU - Jamontt, Joanna

AU - Robson, Philip

PY - 2009/1/8

Y1 - 2009/1/8

N2 - The present invention relates to the use of a substantially pure tetrahydrocannabinol (THC) or a THC containing extract in which THC is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. A further embodiment of the invention relates to the use of a substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. Additionally the substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid are used in the manufacture of a medicament for use as an adjunct therapy in the treatment of an inflammatory bowel disease.

AB - The present invention relates to the use of a substantially pure tetrahydrocannabinol (THC) or a THC containing extract in which THC is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. A further embodiment of the invention relates to the use of a substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. Additionally the substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid are used in the manufacture of a medicament for use as an adjunct therapy in the treatment of an inflammatory bowel disease.

M3 - Patent

M1 - WO2009004302

ER -

Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease

Abstract

Fingerprint

Cite this